Jeffrey S. Heier, Chief Scientific Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 3,057 shares at $8.28 ($25K) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Open-market sale of $25k OCUL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-05-28 | $25K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $42K | — | Filing → |
| OCUL | SELL | 2025-10-06 | $232K | — | Filing → |